A phase I/II trial of SP 102 inpatients with lumbar radiculopathy

Trial Profile

A phase I/II trial of SP 102 inpatients with lumbar radiculopathy

Completed
Phase of Trial: Phase I/II

Latest Information Update: 26 Jun 2017

At a glance

  • Drugs SP 102 (Primary)
  • Indications Radiculopathy
  • Focus Adverse reactions; First in man; Proof of concept
  • Most Recent Events

    • 26 Jun 2017 According to a Semnur Pharmaceuticals media release, detailed data from this trial is expected at upcoming meetings.
    • 26 Jun 2017 Status changed from recruiting to completed, according to a Semnur Pharmaceuticals media release.
    • 26 Jun 2017 Data from this trial published in a Semnur Pharmaceuticals Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top